Stiripentol exhibits higher anticonvulsant properties in the immature than in the mature rat brain

Epilepsia

Volumn 54, Issue 12, 2013, Pages 2082-2090

  Auvin, Stéphane ^a,b   Lecointe, Cécile ^a,b   Dupuis, Nina ^a,b   Desnous, Béatrice ^a,b   Lebon, Sophie ^a,b   Gressens, Pierre ^a,b   Dournaud, Pascal ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSERM   (France)

Author keywords

Antiepileptic drugs; Pentylenetetrazol; Seizure; Status epilepticus; Stiripentol

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; CHLORIDE; DIAZEPAM; LITHIUM; MESSENGER RNA; PENTETRAZOLE; PILOCARPINE; STIRIPENTOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN CELL; BRAIN DAMAGE; CHLORIDE TRANSPORT; CONTROLLED STUDY; DENTATE GYRUS; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; EPILEPTIC STATE; HIPPOCAMPAL CA1 REGION; HISTOPATHOLOGY; LATENT PERIOD; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TONIC CLONIC SEIZURE;

EID: 84890126034     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12401     Document Type: Article

References (31)

1. Auvin S, Shin D, Mazarati A, Sankar R,. (2006) The utility of testing pentylenetetrazol threshold. Epilepsia 47: 662-663.
2. Auvin S, Dulac O, Vallee L,. (2008) Do SCN1A mutations protect from hippocampal sclerosis? Epilepsia 49: 1107-1108.
3. Auvin S, Pineda E, Shin D, Gressens P, Mazarati A,. (2012) Novel animal models of pediatric epilepsy. Neurotherapeutics 9: 245-261.
4. Cao DZ, Ohtani H, Ogiwara I, Ohtani S, Takahashi Y, Yamakawa K, Inoue Y,. (2012) Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome. Epilepsia 53: 1140-1145.
5. Catarino CB, Liu JYW, Liagkouras I, Gibbons VS, Labrum RW, Ellis R, Woodward C, Davis MB, Smith SJ, Cross JH, Appleton RE, Yendle SC, McMahon JM, Bellows ST, Jacques TS, Zuberi SM, Koepp MJ, Martinian L, Scheffer IE, Thom M, Sisodiya SM,. (2011) Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain 134: 2982-3010.
6. Chiron C, Marchand MC, Tran A, Rey E, d'Athis P, Vincent J, Dulac O, Pons G, Grp SS,. (2000) Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. Lancet 356: 1638-1642.
7. Coppola G, Plouin P, Chiron C, Robain O, Dulac O,. (1995) Migrating partial seizures in infancy-a malignant disorder with developmental arrest. Epilepsia 36: 1017-1024.
8. Djuric M, Kravljanac R, Kovacevic G, Martic J,. (2011) The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy. Epileptic Disord 13: 22-26.
9. Fisher JL,. (2009) The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator. Neuropharmacology 56: 190-197.
10. Francois J, Koning E, Ferrandon A, Nehlig A,. (2006) The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res 72: 147-163.
11. Giraud C, Treluyer JM, Rey E, Chiron C, Vincent J, Pons G, Tran A,. (2006) In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism. Drug Metab Dispos 34: 608-611.
12. Laurie DJ, Wisden W, Seeburg PH,. (1992) The distribution of 13 GABA-A receptor subunit messenger-RNAs in the rat-brain. 3. Embryonic and postnatal-development. J Neurosci 12: 4151-4172.
13. Lockard JS, Levy RH, Rhodes PH, Moore DF,. (1985) Stiripentol in acute chronic efficacy tests in monkey model. Epilepsia 26: 704-712.
14. Loiseau P, Strube E, Tor J, Levy RH, Dodrill C,. (1988) Neuropsychological and efficacy evaluation of stiripentol in epileptic patients. Rev Neurol 144: 165-172.
15. Luszczki JJ, Trojnar MK, Ratnaraj N, Patsalos PN, Czuczwar SJ,. (2010) Interactions of stiripentol with clobazam and valproate in the mouse maximal electroshock-induced seizure model. Epilepsy Res 90: 188-198.
16. Mares P,. (2012) Models of epileptic seizures in immature rats. Physiol Res 61: 103-108.
17. Martinezlage JM, Loiseau P, Levy RH, Gonzalez I, Strube E, Tor J, Blehaut H,. (1984) Clinical antiepileptic efficacy of stiripentol in resistant partial epilepsies. Epilepsia 25: 673.
18. Merdariu D, Delanoe C, Mafoufi N, Bellavoine V, Auvin S,. (2013) Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam. Brain Dev 35: 177-180.
19. Perez J, Chiron C, Musial C, Rey E, Blehaut H, d'Athis JP, Vincent J, Dulac O,. (1999) Stiripentol: Efficacy and tolerability in children with epilepsy. Epilepsia 40: 1618-1626.
20. Poisson M, Huguet F, Savattier A, Bakrilogeais F, Narcisse G,. (1984) A new type of anticonvulsant, stiripentol-pharmacological profile and neurochemical study. Arzneimittelforschung 34: 199-204.
21. Quilichini PP, Chiron C, Ben-Ari Y, Gozlan H,. (2006) Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA(A)-receptor channels. Epilepsia 47: 704-716.
22. Sakakibara T, Nakagawa E, Saito Y, Sakuma H, Komaki H, Sugai K, Sasaki M, Kurahashi H, Hirose S,. (2009) Hemiconvulsion-hemiplegia syndrome in a patient with severe myoclonic epilepsy in infancy. Epilepsia 50: 2158-2162.
23. Sankar R, Shin DH, Liu HT, Mazarati A, de Vasconcelos AP, Wasterlain CG,. (1998) Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci 18: 8382-8393.
24. Shen DD, Levy RH, Moor MJ, Savitch JL,. (1990) Efficacy of stiripentol in the intravenous pentylenetetrazol infusion seizure model in the rat. Epilepsy Res 7: 40-48.
25. Shen DD, Levy RH, Savitch JL, Boddy AV, Tombret F, Lepage F,. (1992) Comparative anticonvulsant potency and pharmacokinetics of (+)- and (-)-enantiomers of stiripentol. Epilepsy Res 12: 29-36.
26. Sperk G, Furtinger S, Schwarzer C, Pirker S,. (2004) GABA and its receptors in epilepsy. In, Binder DK, Scharfman HE, (Eds) Recent advances in epilepsy research. Vol. 548. Kluwer Academic, New York, pp. 92-103.
27. Tang S, Lin JP, Hughes E, Siddiqui A, Lim M, Lascelles K,. (2011) Encephalopathy and SCN1A mutations. Epilepsia 52: E26-E30.
28. Tran A, VauzelleKervroedan F, Rey E, Pons G, dAthis P, Chiron C, Dulac O, Renard F, Olive G,. (1996) Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children. Eur J Clin Pharmacol 50: 497-500.
29. Trojnar MK, Wojtal K, Trojnar MP, Czuczwar SJ,. (2005) Stiripentol. A novel antiepileptic drug. Pharmacol Rep 57: 154-160.
30. Yu ZY, Wang W, Fritschy JM, Witte OW, Redecker C,. (2006) Changes in neocortical and hippocampal GABA(A) receptor subunit distribution during brain maturation and aging. Brain Res 1099: 73-81.
31. Zhang NH, Wei WZ, Mody I, Houser CR,. (2007) Altered localization of GABAA receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J Neurosci 27: 7520-7531.